CASPOFUNGIN ACETATE

CASPOFUNGIN ACETATE was reported 1586 times

CASPOFUNGIN ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPLENIC CANDIDIASIS 8 0.3478
1 GRANULICATELLA INFECTION 8 0.1905
2 UPPER RESPIRATORY FUNGAL INFECTION 32 0.1684
3 AORTOENTERIC FISTULA 10 0.1562
4 PROTOTHECOSIS 14 0.1489
5 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 34 0.1466
6 DYSPLASTIC NAEVUS 35 0.0970
7 SYSTEMIC MYCOSIS 110 0.0942
8 PHOTODERMATOSIS 35 0.0829
9 ARTERITIS INFECTIVE 5 0.0820
10 ENCEPHALITIS FUNGAL 7 0.0778
11 MYCOTIC ENDOPHTHALMITIS 13 0.0688
12 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 5 0.0658
13 PYELONEPHRITIS FUNGAL 4 0.0541
14 ALTERNARIA INFECTION 20 0.0538
15 CYTARABINE SYNDROME 4 0.0526
16 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 48 0.0507
17 GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0462
18 ABSCESS FUNGAL 8 0.0457
19 DILATATION INTRAHEPATIC DUCT ACQUIRED 13 0.0445
20 DECEREBRATION 5 0.0439
21 LOWER RESPIRATORY TRACT INFECTION FUNGAL 17 0.0437
22 SPLENIC ABSCESS 17 0.0418
23 DISSEMINATED TRICHOSPORONOSIS 3 0.0417
24 ISCHAEMIC ENTERITIS 4 0.0412
25 SYSTEMIC CANDIDA 101 0.0402
26 FUNGAL ENDOCARDITIS 12 0.0399
27 ENDOCARDITIS CANDIDA 3 0.0395
28 ASPERGILLOSIS 51 0.0390
29 HYDROPNEUMOTHORAX 4 0.0388
30 INTRAOCULAR PRESSURE TEST 9 0.0375
31 SOLAR LENTIGO 35 0.0369
32 FUSARIUM INFECTION 23 0.0329
33 TRICHOSPORON INFECTION 13 0.0321
34 SCEDOSPORIUM INFECTION 22 0.0312
35 ZYGOMYCOSIS 13 0.0278
36 CEREBRAL ASPERGILLOSIS 17 0.0276
37 COAGULATION FACTOR V LEVEL DECREASED 9 0.0275
38 PERINEPHRIC ABSCESS 4 0.0263
39 EYE INFECTION FUNGAL 10 0.0258
40 FUNGAL TEST POSITIVE 9 0.0256
41 MYOGLOBINAEMIA 3 0.0254
42 HEPATIC INFECTION FUNGAL 3 0.0250
43 CHRONIC GRANULOMATOUS DISEASE 2 0.0244
44 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 5 0.0240
45 CANDIDA SEPSIS 21 0.0234
46 DIFFERENTIATION SYNDROME 17 0.0232
47 CYTOTOXIC OEDEMA 6 0.0226
48 CHIMERISM 2 0.0225
49 EMPHYSEMATOUS PYELONEPHRITIS 4 0.0219
50 ENTEROCOCCAL SEPSIS 17 0.0210
51 FUNGAEMIA 33 0.0210
52 URINARY TRACT CANDIDIASIS 4 0.0209
53 RED BLOOD CELLS URINE POSITIVE 20 0.0207
54 MECHANICAL VENTILATION COMPLICATION 3 0.0201
55 IDIOPATHIC PNEUMONIA SYNDROME 6 0.0201
56 GRAFT VERSUS HOST DISEASE IN LIVER 14 0.0196
57 HYPERLEUKOCYTOSIS 17 0.0192
58 CRYSTAL ARTHROPATHY 4 0.0190
59 EXTRASKELETAL OSSIFICATION 4 0.0186
60 RECTAL PERFORATION 10 0.0186
61 RASH SCARLATINIFORM 4 0.0181
62 FUNGAL SEPSIS 15 0.0181
63 INCISION SITE PAIN 20 0.0170
64 BRONCHOPLEURAL FISTULA 6 0.0160
65 ASPERGILLUS INFECTION 94 0.0143
66 GEOTRICHUM INFECTION 3 0.0142
67 CEREBRAL FUNGAL INFECTION 4 0.0141
68 BRONCHOPULMONARY ASPERGILLOSIS 108 0.0139
69 ENGRAFTMENT SYNDROME 8 0.0135
70 ACTINIC KERATOSIS 35 0.0135
71 DISSEMINATED ASPERGILLOSIS 6 0.0127
72 GAS GANGRENE 4 0.0117
73 ACUTE MYELOID LEUKAEMIA REFRACTORY 2 0.0116
74 BILE ACIDS INCREASED 2 0.0113
75 RESPIRATORY MONILIASIS 3 0.0112
76 DEHISCENCE 2 0.0106
77 GRAFT VERSUS HOST DISEASE IN LUNG 5 0.0105
78 HYPOPERFUSION 11 0.0105
79 ENGRAFT FAILURE 3 0.0105
80 SUBCUTANEOUS EMPHYSEMA 10 0.0102
81 BILIARY CIRRHOSIS 2 0.0100
82 VESICOURETERIC REFLUX 4 0.0099
83 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 4 0.0099
84 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 3 0.0097
85 COLONY STIMULATING FACTOR THERAPY 2 0.0097
86 AMAUROSIS 8 0.0095
87 RESPIRATORY TRACT INFECTION FUNGAL 5 0.0095
88 POLYSEROSITIS 4 0.0094
89 GASTROENTERITIS BACTERIAL 3 0.0091
90 HYPOPROTEINAEMIA 17 0.0090
91 GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0086
92 ADENOVIRAL HEPATITIS 2 0.0085
93 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 12 0.0085
94 DELAYED GRAFT FUNCTION 6 0.0084
95 SEPTIC EMBOLUS 7 0.0084
96 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0083
97 PATHOGEN RESISTANCE 75 0.0082
98 ESCHAR 6 0.0082
99 ENTEROBACTER TEST POSITIVE 2 0.0081
100 INFECTIVE ANEURYSM 4 0.0081
101 MUCORMYCOSIS 21 0.0081
102 BLOOD CULTURE POSITIVE 24 0.0080
103 LIVER ABSCESS 26 0.0080
104 NOSOCOMIAL INFECTION 17 0.0077
105 BACTEROIDES INFECTION 2 0.0077
106 METAPNEUMOVIRUS INFECTION 6 0.0077
107 ENTEROCOCCAL BACTERAEMIA 8 0.0075
108 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 16 0.0075
109 CANDIDIASIS 30 0.0075
110 INCISION SITE IMPAIRED HEALING 3 0.0074
111 PARVOVIRUS INFECTION 3 0.0074
112 ANTITHROMBIN III DECREASED 2 0.0073
113 VENOOCCLUSIVE LIVER DISEASE 36 0.0073
114 CANDIDA TEST POSITIVE 3 0.0072
115 LUNG INFECTION PSEUDOMONAL 4 0.0072
116 GRAFT VERSUS HOST DISEASE 50 0.0069
117 CAPILLARY LEAK SYNDROME 14 0.0068
118 EPIDERMOLYSIS 3 0.0065
119 COAGULATION TEST ABNORMAL 5 0.0065
120 HEPATITIS FULMINANT 19 0.0064
121 RENAL TUBULAR DISORDER 18 0.0064
122 VENOOCCLUSIVE DISEASE 16 0.0064
123 HYPERBILIRUBINAEMIA 65 0.0063
124 ASPERGILLOMA 2 0.0063
125 BLOOD BICARBONATE INCREASED 3 0.0062
126 CANDIDA PNEUMONIA 2 0.0062
127 MULTI-ORGAN FAILURE 107 0.0062
128 TOXIC SKIN ERUPTION 62 0.0061
129 HAEMATOLOGICAL INFECTION 15 0.0061
130 RENAL ABSCESS 5 0.0061
131 SPINAL CORD DISORDER 10 0.0061
132 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
133 CHOLESTASIS 112 0.0058
134 GASTROINTESTINAL FUNGAL INFECTION 3 0.0058
135 SQUAMOUS CELL CARCINOMA OF SKIN 35 0.0058
136 SKIN CANDIDA 3 0.0057
137 BLAST CELL COUNT INCREASED 6 0.0057
138 PULMONARY MUCORMYCOSIS 3 0.0057
139 APLASIA 11 0.0056
140 BLOOD ALKALINE PHOSPHATASE ABNORMAL 5 0.0056
141 MUCOSAL EROSION 5 0.0055
142 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
143 URINARY TRACT INFECTION ENTEROCOCCAL 5 0.0054
144 ENTEROBACTER INFECTION 9 0.0054
145 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151 0.0053
146 LEUKAEMIA RECURRENT 9 0.0053
147 BLOOD FIBRINOGEN DECREASED 6 0.0053
148 CARDIORENAL SYNDROME 3 0.0052
149 URINARY TRACT INFECTION FUNGAL 3 0.0052
150 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
151 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
152 AMYOTROPHY 2 0.0052
153 BILIRUBIN CONJUGATED INCREASED 12 0.0051
154 CENTRAL NERVOUS SYSTEM LEUKAEMIA 2 0.0051
155 HISTIOCYTOSIS HAEMATOPHAGIC 15 0.0050
156 RESPIRATORY TRACT HAEMORRHAGE 3 0.0050
157 FEBRILE BONE MARROW APLASIA 21 0.0049
158 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
159 MONOCYTOSIS 3 0.0048
160 CYTOLYTIC HEPATITIS 16 0.0048
161 PNEUMONIA FUNGAL 19 0.0048
162 PROTEIN URINE PRESENT 24 0.0048
163 ACUTE GRAFT VERSUS HOST DISEASE 22 0.0048
164 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
165 HEPATIC INFECTION 6 0.0047
166 CHORIORETINITIS 3 0.0047
167 ENTEROCOCCUS TEST POSITIVE 3 0.0046
168 NECROTISING MYOSITIS 4 0.0046
169 DERMATITIS EXFOLIATIVE 23 0.0046
170 ACUTE LYMPHOCYTIC LEUKAEMIA 13 0.0046
171 ELEVATED MOOD 2 0.0046
172 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
173 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 117 0.0045
174 SEPTIC SHOCK 197 0.0045
175 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 35 0.0045
176 CONGESTIVE HEPATOPATHY 2 0.0045
177 FUNGAL SKIN INFECTION 18 0.0045
178 DELUSION OF GRANDEUR 2 0.0045
179 CAECITIS 2 0.0044
180 KLEBSIELLA SEPSIS 5 0.0044
181 STENOTROPHOMONAS INFECTION 6 0.0044
182 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
183 PUNCTATE KERATITIS 4 0.0044
184 DRUG RESISTANCE 112 0.0044
185 PROTHROMBIN TIME ABNORMAL 3 0.0043
186 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
187 AGRANULOCYTOSIS 79 0.0042
188 CANDIDA INFECTION 71 0.0042
189 CARDIAC VALVE VEGETATION 2 0.0041
190 PSEUDOMONAS INFECTION 35 0.0041
191 CELL DEATH 8 0.0040
192 SERRATIA INFECTION 3 0.0040
193 ACQUIRED HAEMOPHILIA 4 0.0040
194 ORGAN FAILURE 16 0.0040
195 ASPARTATE AMINOTRANSFERASE ABNORMAL 6 0.0039
196 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0039
197 BLOOD BILIRUBIN ABNORMAL 5 0.0039
198 HEPATOCELLULAR INJURY 55 0.0039
199 ACQUIRED IMMUNODEFICIENCY SYNDROME 2 0.0039
200 ADENOVIRUS INFECTION 11 0.0038
201 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
202 KLEBSIELLA INFECTION 19 0.0038
203 SINUSITIS FUNGAL 3 0.0037
204 PERFORATION 3 0.0037
205 HAPTOGLOBIN DECREASED 3 0.0037
206 FUNGAL INFECTION 124 0.0037
207 TOXOPLASMOSIS 4 0.0037
208 ENDOCARDITIS 19 0.0037
209 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0037
210 JAUNDICE CHOLESTATIC 13 0.0037
211 HAEMORRHAGIC DISORDER 4 0.0037
212 PSEUDOMONAS TEST POSITIVE 3 0.0037
213 ACINETOBACTER INFECTION 4 0.0037
214 CEREBELLAR SYNDROME 8 0.0036
215 CHOLESTATIC LIVER INJURY 8 0.0036
216 VANISHING BILE DUCT SYNDROME 4 0.0036
217 PROTHROMBIN TIME SHORTENED 5 0.0036
218 NEUTROPHIL COUNT INCREASED 36 0.0035
219 ACUTE SINUSITIS 6 0.0035
220 CYSTITIS HAEMORRHAGIC 14 0.0035
221 MUCOSAL HAEMORRHAGE 4 0.0034
222 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
223 PSEUDOMONAL SEPSIS 6 0.0034
224 RED MAN SYNDROME 3 0.0034
225 ABDOMINAL SEPSIS 3 0.0034
226 NEUTROPENIC COLITIS 7 0.0034
227 CLOSTRIDIUM COLITIS 4 0.0033
228 ACUTE MYELOID LEUKAEMIA RECURRENT 7 0.0033
229 BONE MARROW TRANSPLANT 6 0.0032
230 MECHANICAL VENTILATION 6 0.0032
231 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
232 LYMPHOCYTE COUNT DECREASED 55 0.0031
233 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
234 HEPATITIS TOXIC 8 0.0031
235 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
236 ACUTE PULMONARY OEDEMA 17 0.0030
237 EOSINOPHILIA 53 0.0030
238 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
239 HYPERNATRAEMIA 15 0.0030
240 ACUTE RESPIRATORY DISTRESS SYNDROME 53 0.0030
241 MIXED LIVER INJURY 9 0.0030
242 BRONCHITIS VIRAL 2 0.0030
243 CATHETER RELATED INFECTION 3 0.0030
244 BONE MARROW FAILURE 60 0.0029
245 BACTERAEMIA 35 0.0029
246 HYPOMAGNESAEMIA 41 0.0029
247 ENTERITIS INFECTIOUS 5 0.0029
248 URETERIC OBSTRUCTION 4 0.0029
249 AMYLOIDOSIS 5 0.0029
250 ENTEROCOCCAL INFECTION 14 0.0029
251 BILIARY TRACT DISORDER 4 0.0029
252 ANASTOMOTIC LEAK 2 0.0029
253 TRANSPLANT FAILURE 7 0.0029
254 STAPHYLOCOCCAL SEPSIS 14 0.0028
255 HEPATITIS CHOLESTATIC 17 0.0028
256 CHRONIC GRAFT VERSUS HOST DISEASE 10 0.0028
257 PNEUMOMEDIASTINUM 5 0.0028
258 BACTERIAL SEPSIS 9 0.0028
259 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
260 ABDOMINAL INFECTION 7 0.0027
261 PNEUMONIA KLEBSIELLA 5 0.0027
262 STREPTOCOCCAL INFECTION 15 0.0027
263 PULMONARY HAEMORRHAGE 21 0.0027
264 MYOCARDIAL INJURY 3 0.0027
265 COMPLICATIONS OF TRANSPLANTED KIDNEY 6 0.0026
266 BRONCHITIS BACTERIAL 2 0.0026
267 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
268 BLOOD POTASSIUM ABNORMAL 7 0.0026
269 RASH MACULO-PAPULAR 58 0.0026
270 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
271 ENTEROCOLITIS 15 0.0026
272 ACUTE MYELOID LEUKAEMIA 40 0.0026
273 FEBRILE NEUTROPENIA 170 0.0026
274 RECTAL ULCER 3 0.0026
275 ESCHERICHIA BACTERAEMIA 6 0.0025
276 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
277 INTESTINAL ISCHAEMIA 14 0.0025
278 BONE MARROW TOXICITY 3 0.0025
279 ENCEPHALOPATHY 62 0.0025
280 ESCHERICHIA TEST POSITIVE 3 0.0025
281 ELECTROMECHANICAL DISSOCIATION 2 0.0025
282 BILE DUCT STENOSIS 3 0.0025
283 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 3 0.0025
284 DIABETES INSIPIDUS 6 0.0025
285 ENDOMETRIAL HYPERPLASIA 2 0.0025
286 ENCEPHALITIS VIRAL 3 0.0025
287 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
288 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
289 HYPOKALAEMIA 112 0.0024
290 CULTURE POSITIVE 2 0.0024
291 BRAIN ABSCESS 6 0.0024
292 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
293 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
294 HAEMODYNAMIC INSTABILITY 18 0.0024
295 POSTOPERATIVE WOUND COMPLICATION 3 0.0024
296 STEVENS-JOHNSON SYNDROME 52 0.0023
297 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
298 TORSADE DE POINTES 18 0.0023
299 CYTOMEGALOVIRUS INFECTION 38 0.0023
300 BLOOD ALBUMIN DECREASED 18 0.0023
301 OESOPHAGEAL HAEMORRHAGE 3 0.0023
302 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
303 MULTIPLE-DRUG RESISTANCE 7 0.0023
304 BLOOD ALBUMIN INCREASED 2 0.0022
305 BLOOD BILIRUBIN INCREASED 60 0.0022
306 ANAEMIA OF CHRONIC DISEASE 2 0.0022
307 MUCOUS MEMBRANE DISORDER 3 0.0022
308 EFFUSION 3 0.0022
309 HYPERURICAEMIA 9 0.0022
310 HYPOALBUMINAEMIA 17 0.0022
311 PROTHROMBIN TIME PROLONGED 13 0.0022
312 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
313 VIRAEMIA 3 0.0022
314 GRANULOCYTE COUNT DECREASED 4 0.0022
315 DEATH NEONATAL 3 0.0022
316 BLOOD UREA INCREASED 36 0.0021
317 HEPATIC NECROSIS 8 0.0021
318 PHOTOSENSITIVITY REACTION 35 0.0021
319 TRACHEOSTOMY 3 0.0021
320 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
321 CEREBELLAR ATAXIA 2 0.0021
322 KIDNEY TRANSPLANT REJECTION 10 0.0021
323 PARAPLEGIA 6 0.0021
324 HAEMOTHORAX 6 0.0021
325 LYMPHADENITIS 5 0.0021
326 GASTROINTESTINAL NECROSIS 6 0.0021
327 HEPATIC FAILURE 62 0.0021
328 WOUND COMPLICATION 7 0.0020
329 DUODENAL PERFORATION 2 0.0020
330 HEPATIC FUNCTION ABNORMAL 75 0.0020
331 SUPERINFECTION 3 0.0020
332 BACTERIAL INFECTION 37 0.0020
333 CRANIOCEREBRAL INJURY 6 0.0020
334 MYOCLONIC EPILEPSY 3 0.0020
335 FUNGAL PERITONITIS 3 0.0020
336 HEPATIC CYTOLYSIS 25 0.0020
337 HEPATOSPLENOMEGALY 5 0.0019
338 QUADRIPLEGIA 4 0.0019
339 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
340 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
341 VENTRICULAR DYSFUNCTION 5 0.0019
342 CUTANEOUS VASCULITIS 7 0.0019
343 ORAL CANDIDIASIS 25 0.0019
344 PANCYTOPENIA 105 0.0019
345 METABOLIC ALKALOSIS 3 0.0019
346 HYPERLACTACIDAEMIA 5 0.0019
347 PROTEIN TOTAL DECREASED 7 0.0019
348 ANURIA 16 0.0019
349 FACIAL PALSY 4 0.0019
350 PURPURA 16 0.0018
351 HAEMORRHAGE INTRACRANIAL 27 0.0018
352 RASH MORBILLIFORM 5 0.0018
353 HEMIPLEGIA 15 0.0018
354 TRANSAMINASES INCREASED 40 0.0018
355 RESPIRATORY FAILURE 131 0.0018
356 CARDIOPULMONARY FAILURE 7 0.0018
357 PSEUDOMEMBRANOUS COLITIS 4 0.0018
358 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
359 CEREBELLAR INFARCTION 3 0.0018
360 HEPATOCELLULAR DAMAGE 4 0.0018
361 OLIGURIA 11 0.0018
362 NEUROPATHY 3 0.0018
363 BRONCHOPNEUMONIA 6 0.0018
364 LICHENOID KERATOSIS 4 0.0017
365 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
366 PUSTULAR PSORIASIS 6 0.0017
367 BRAIN OEDEMA 22 0.0017
368 SEPSIS 192 0.0017
369 ACIDOSIS 13 0.0017
370 LUNG INFILTRATION 15 0.0017
371 COCCIDIOIDOMYCOSIS 2 0.0017
372 DYSPLASIA 2 0.0017
373 HEPATOTOXICITY 37 0.0017
374 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
375 OPPORTUNISTIC INFECTION 3 0.0016
376 COAGULOPATHY 27 0.0016
377 HEPATIC LESION 7 0.0016
378 BLOOD UREA DECREASED 2 0.0016
379 STEM CELL TRANSPLANT 4 0.0016
380 AORTIC VALVE REPLACEMENT 2 0.0016
381 STATUS EPILEPTICUS 18 0.0016
382 HEPATIC MASS 3 0.0016
383 SKIN NECROSIS 8 0.0015
384 C-REACTIVE PROTEIN INCREASED 56 0.0015
385 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
386 VENTRICULAR FIBRILLATION 17 0.0015
387 PYELONEPHRITIS ACUTE 3 0.0015
388 OCCULT BLOOD POSITIVE 3 0.0015
389 PNEUMONIA BACTERIAL 14 0.0015
390 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
391 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
392 LIVER FUNCTION TEST ABNORMAL 44 0.0015
393 HYPOPHOSPHATAEMIA 11 0.0015
394 ASPARTATE AMINOTRANSFERASE INCREASED 79 0.0015
395 WOUND DEHISCENCE 5 0.0015
396 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
397 ACUTE HEPATIC FAILURE 20 0.0015
398 CHOLANGITIS SCLEROSING 3 0.0015
399 WHITE BLOOD CELL COUNT INCREASED 56 0.0015
400 VIITH NERVE PARALYSIS 5 0.0014
401 HYPERTHERMIA 11 0.0014
402 RENAL FAILURE ACUTE 61 0.0014
403 LUNG ABSCESS 3 0.0014
404 HAEMODIALYSIS 12 0.0014
405 NEUTROPHIL COUNT DECREASED 58 0.0014
406 ALVEOLITIS 2 0.0014
407 TORTICOLLIS 3 0.0014
408 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
409 ACUTE RESPIRATORY FAILURE 27 0.0014
410 ALANINE AMINOTRANSFERASE INCREASED 86 0.0014
411 PERITONITIS 29 0.0014
412 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
413 NEOPLASM PROGRESSION 48 0.0014
414 ESCHERICHIA SEPSIS 4 0.0014
415 HENOCH-SCHONLEIN PURPURA 3 0.0014
416 BLOOD PHOSPHORUS DECREASED 5 0.0014
417 HYPOVOLAEMIA 8 0.0014
418 CLOSTRIDIUM TEST POSITIVE 3 0.0014
419 RETROPERITONEAL HAEMATOMA 3 0.0014
420 SHOCK HAEMORRHAGIC 11 0.0013
421 PNEUMOCYSTIS JIROVECI PNEUMONIA 3 0.0013
422 SINUS BRADYCARDIA 13 0.0013
423 URINE ANALYSIS ABNORMAL 4 0.0013
424 NEPHROPATHY TOXIC 15 0.0013
425 METABOLIC ENCEPHALOPATHY 4 0.0013
426 DRUG LEVEL INCREASED 22 0.0013
427 HEPATITIS 34 0.0013
428 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
429 PORTAL HYPERTENSION 4 0.0013
430 CHOLANGITIS 8 0.0013
431 BLOOD CREATININE DECREASED 4 0.0013
432 PNEUMOTHORAX 20 0.0013
433 MUCOSAL INFLAMMATION 33 0.0013
434 LEUKOPENIA 63 0.0013
435 SKIN EROSION 4 0.0012
436 PORTAL VEIN THROMBOSIS 4 0.0012
437 RESPIRATORY DISTRESS 34 0.0012
438 HEPATITIS ACUTE 8 0.0012
439 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
440 CRYPTOCOCCOSIS 2 0.0012
441 JAUNDICE 33 0.0012
442 NEUROLOGICAL SYMPTOM 7 0.0012
443 DRUG-INDUCED LIVER INJURY 38 0.0012
444 TACHYARRHYTHMIA 3 0.0012
445 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
446 MYELOSUPPRESSION 43 0.0012
447 BRONCHOSPASM 17 0.0012
448 DEAFNESS BILATERAL 2 0.0012
449 BLOOD PH DECREASED 2 0.0012
450 BLOOD CHLORIDE INCREASED 2 0.0012
451 PERIORBITAL OEDEMA 6 0.0012
452 LARGE INTESTINE PERFORATION 8 0.0012
453 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
454 LOGORRHOEA 4 0.0011
455 GENERALISED OEDEMA 14 0.0011
456 AORTIC VALVE STENOSIS 2 0.0011
457 ANAL ABSCESS 6 0.0011
458 PANCREATITIS ACUTE 25 0.0011
459 HAEMATOCRIT DECREASED 22 0.0011
460 SUSPECTED OFF LABEL USE 5 0.0011
461 MYELODYSPLASTIC SYNDROME 16 0.0011
462 BLOOD CREATININE INCREASED 72 0.0011
463 CYTOKINE RELEASE SYNDROME 22 0.0011
464 MACULE 3 0.0011
465 HYPOXIA 38 0.0011
466 NECROSIS 6 0.0011
467 LEUKOENCEPHALOPATHY 4 0.0011
468 MALNUTRITION 12 0.0011
469 CHOLECYSTITIS ACUTE 6 0.0011
470 HYPERCALCAEMIA 13 0.0011
471 THROMBOCYTOPENIA 117 0.0010
472 HYPOVOLAEMIC SHOCK 5 0.0010
473 LUNG INFECTION 16 0.0010
474 ASCITES 30 0.0010
475 LIVER INJURY 25 0.0010
476 RESPIRATORY ACIDOSIS 4 0.0010
477 ORGANISING PNEUMONIA 5 0.0010
478 EMPYEMA 2 0.0010
479 BRAIN HERNIATION 3 0.0010
480 SHOCK 23 0.0010
481 HYPERCAPNIA 3 0.0010
482 HIV INFECTION 3 0.0010
483 BONE MARROW DISORDER 3 0.0010
484 VARICES OESOPHAGEAL 3 0.0010
485 CHEST X-RAY ABNORMAL 3 0.0010
486 PHLEBITIS 5 0.0010
487 DIASTOLIC DYSFUNCTION 3 0.0010
488 DIVERTICULAR PERFORATION 2 0.0010
489 RENAL FAILURE 129 0.0010
490 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
491 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
492 APLASTIC ANAEMIA 5 0.0010
493 LEUKAEMIA 9 0.0010
494 DILATATION VENTRICULAR 2 0.0010
495 HYPOCALCAEMIA 18 0.0010
496 CEREBRAL HAEMORRHAGE 34 0.0009
497 BLOOD LACTIC ACID INCREASED 5 0.0009
498 HYPERPYREXIA 4 0.0009
499 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
500 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
501 ENTERITIS 6 0.0009
502 VENTRICULAR HYPOKINESIA 3 0.0009
503 PLATELET COUNT DECREASED 99 0.0009
504 THROMBOTIC MICROANGIOPATHY 9 0.0009
505 URINE OUTPUT DECREASED 8 0.0009
506 HYPOGAMMAGLOBULINAEMIA 6 0.0009
507 TUMOUR LYSIS SYNDROME 8 0.0009
508 DIABETIC NEPHROPATHY 2 0.0009
509 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
510 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
511 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
512 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
513 ILEUS PARALYTIC 4 0.0009
514 BK VIRUS INFECTION 3 0.0009
515 PLEURAL EFFUSION 54 0.0009
516 CARDIO-RESPIRATORY ARREST 37 0.0009
517 TACHYPNOEA 12 0.0009
518 GENERALISED ERYTHEMA 5 0.0009
519 EYE MOVEMENT DISORDER 6 0.0009
520 APLASIA PURE RED CELL 3 0.0009
521 LEFT VENTRICULAR FAILURE 3 0.0009
522 CYTOMEGALOVIRUS COLITIS 2 0.0009
523 ENCEPHALITIS 6 0.0009
524 TYPE I HYPERSENSITIVITY 3 0.0009
525 LUNG TRANSPLANT 3 0.0008
526 PRODUCT USE IN UNAPPROVED INDICATION 210 0.0008
527 HAEMOGLOBIN DECREASED 87 0.0008
528 THERAPY NON-RESPONDER 38 0.0008
529 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
530 CARDIAC TAMPONADE 4 0.0008
531 LYMPHOMA 13 0.0008
532 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
533 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
534 NO THERAPEUTIC RESPONSE 10 0.0008
535 INCORRECT DOSAGE ADMINISTERED 4 0.0008
536 COMA 38 0.0008
537 ACUTE KIDNEY INJURY 122 0.0008
538 LUNG DISORDER 39 0.0008
539 DYSPHORIA 4 0.0008
540 TOXIC ENCEPHALOPATHY 4 0.0008
541 LIVER DISORDER 35 0.0008
542 DRUG INTERACTION 125 0.0008
543 TONGUE OEDEMA 3 0.0008
544 AMMONIA INCREASED 4 0.0008
545 DELIRIUM 27 0.0008
546 HAEMOLYSIS 6 0.0008
547 BLOOD CHLORIDE DECREASED 2 0.0008
548 UNRESPONSIVE TO STIMULI 20 0.0008
549 PNEUMONITIS 21 0.0008
550 FACE OEDEMA 13 0.0008
551 MALABSORPTION 4 0.0008
552 PARTIAL SEIZURES 4 0.0008
553 OEDEMA 41 0.0008
554 RENAL CYST 6 0.0008
555 OESOPHAGEAL CANDIDIASIS 3 0.0008
556 HEPATIC ENCEPHALOPATHY 7 0.0007
557 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
558 MUSCLE HAEMORRHAGE 3 0.0007
559 NEUROTOXICITY 13 0.0007
560 RENAL IMPAIRMENT 62 0.0007
561 NEUTROPENIA 100 0.0007
562 HYDROCEPHALUS 4 0.0007
563 CLUMSINESS 2 0.0007
564 BLOOD PHOSPHORUS INCREASED 2 0.0007
565 OESOPHAGITIS 8 0.0007
566 ARTHRITIS BACTERIAL 3 0.0007
567 ECCHYMOSIS 5 0.0007
568 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
569 PROCEDURAL PAIN 20 0.0007
570 EOSINOPHIL COUNT INCREASED 6 0.0007
571 CONGESTIVE CARDIOMYOPATHY 3 0.0007
572 DEVICE RELATED INFECTION 11 0.0007
573 ENDOTRACHEAL INTUBATION 2 0.0007
574 HEPATOMEGALY 7 0.0007
575 WHITE BLOOD CELL COUNT DECREASED 77 0.0007
576 AORTIC VALVE INCOMPETENCE 3 0.0007
577 MYDRIASIS 9 0.0007
578 MYOPATHY 6 0.0007
579 DERMATITIS BULLOUS 5 0.0007
580 RALES 4 0.0007
581 DRUG LEVEL DECREASED 7 0.0007
582 DIVERTICULUM INTESTINAL 3 0.0007
583 PROTEINURIA 13 0.0007
584 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
585 INTERSTITIAL LUNG DISEASE 33 0.0007
586 HAEMOPTYSIS 19 0.0007
587 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
588 NERVOUS SYSTEM DISORDER 21 0.0007
589 HAEMATURIA 23 0.0007
590 ODYNOPHAGIA 4 0.0007
591 RESPIRATORY DISORDER 20 0.0007
592 ANAPHYLACTIC SHOCK 17 0.0007
593 DISEASE COMPLICATION 3 0.0007
594 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
595 LARYNGEAL OEDEMA 4 0.0006
596 NEPHROGENIC ANAEMIA 3 0.0006
597 ATRIOVENTRICULAR BLOCK 5 0.0006
598 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
599 CIRCULATORY COLLAPSE 11 0.0006
600 STAPHYLOCOCCAL INFECTION 21 0.0006
601 LYMPHOPENIA 9 0.0006
602 PNEUMONIA 203 0.0006
603 ATRIAL FIBRILLATION 61 0.0006
604 PANCREATITIS 33 0.0006
605 CARDIAC FAILURE 50 0.0006
606 ATELECTASIS 6 0.0006
607 HERPES SIMPLEX 4 0.0006
608 RESPIRATORY TRACT INFECTION 16 0.0006
609 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
610 ESCHERICHIA INFECTION 5 0.0006
611 ABDOMINAL TENDERNESS 3 0.0006
612 CARDIAC FAILURE ACUTE 4 0.0006
613 SKIN MASS 4 0.0006
614 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
615 B-CELL LYMPHOMA 2 0.0006
616 MYOCLONUS 7 0.0006
617 CACHEXIA 3 0.0006
618 FAILURE TO THRIVE 3 0.0006
619 CONVULSION 33 0.0006
620 DISEASE PROGRESSION 68 0.0006
621 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
622 PYREXIA 197 0.0006
623 BRONCHIOLITIS 2 0.0006
624 ABSCESS 9 0.0006
625 THERMAL BURN 4 0.0006
626 HAEMOLYTIC ANAEMIA 5 0.0006
627 CELLULITIS 28 0.0006
628 BRADYCARDIA 29 0.0005
629 MOUTH HAEMORRHAGE 4 0.0005
630 MELAENA 12 0.0005
631 CARDIAC ARREST 45 0.0005
632 VENTRICULAR TACHYCARDIA 9 0.0005
633 AMYLASE INCREASED 2 0.0005
634 CARDIOMYOPATHY 8 0.0005
635 IMMUNODEFICIENCY 8 0.0005
636 ERYTHEMA MULTIFORME 5 0.0005
637 JOINT STIFFNESS 14 0.0005
638 ARRHYTHMIA 25 0.0005
639 GRANULOCYTOPENIA 3 0.0005
640 CARDIAC VALVE DISEASE 3 0.0005
641 MYOCARDITIS 6 0.0005
642 COMMUNICATION DISORDER 2 0.0005
643 HERPES VIRUS INFECTION 3 0.0005
644 DRUG INEFFECTIVE 684 0.0005
645 HYPERTRIGLYCERIDAEMIA 3 0.0005
646 SPLENOMEGALY 6 0.0005
647 SKIN LESION 14 0.0005
648 PLEURISY 3 0.0005
649 CEREBRAL ATROPHY 2 0.0005
650 AZOTAEMIA 2 0.0005
651 TRANSPLANT REJECTION 4 0.0005
652 HYPOTHERMIA 5 0.0005
653 ANAEMIA 94 0.0005
654 DECUBITUS ULCER 4 0.0005
655 SUBDURAL HAEMATOMA 7 0.0005
656 POLYURIA 4 0.0005
657 CARDIOGENIC SHOCK 7 0.0005
658 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
659 TACHYCARDIA 43 0.0005
660 VENTRICULAR EXTRASYSTOLES 5 0.0005
661 CARDIAC MURMUR 4 0.0005
662 PRODUCT PRESCRIBING ISSUE 10 0.0005
663 EPILEPSY 14 0.0005
664 HYPERKALAEMIA 16 0.0005
665 HEPATIC ENZYME INCREASED 31 0.0005
666 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
667 ABDOMINAL ABSCESS 2 0.0005
668 BLOOD CREATINE INCREASED 2 0.0005
669 DRUG ERUPTION 8 0.0005
670 CEREBRAL INFARCTION 11 0.0004
671 INTESTINAL PERFORATION 5 0.0004
672 COLITIS ISCHAEMIC 3 0.0004
673 POSTOPERATIVE WOUND INFECTION 3 0.0004
674 MITRAL VALVE INCOMPETENCE 5 0.0004
675 DRUG TOXICITY 6 0.0004
676 CONFUSIONAL STATE 71 0.0004
677 TREATMENT FAILURE 36 0.0004
678 PERICARDIAL EFFUSION 10 0.0004
679 HYPERTRANSAMINASAEMIA 3 0.0004
680 HALLUCINATION, VISUAL 9 0.0004
681 MANIA 7 0.0004
682 SQUAMOUS CELL CARCINOMA 4 0.0004
683 SEIZURE 49 0.0004
684 RETINAL HAEMORRHAGE 3 0.0004
685 NEUTROPENIC SEPSIS 3 0.0004
686 HYPOTENSION 84 0.0004
687 MUSCLE RIGIDITY 5 0.0004
688 SEROTONIN SYNDROME 8 0.0004
689 PRESCRIBED OVERDOSE 8 0.0004
690 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
691 FLUID OVERLOAD 6 0.0004
692 RENAL DISORDER 19 0.0004
693 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
694 BLADDER DISORDER 4 0.0004
695 ILEUS 5 0.0004
696 PNEUMONIA ASPIRATION 10 0.0004
697 GENERAL SYMPTOM 3 0.0004
698 DERMATITIS ALLERGIC 5 0.0004
699 TROPONIN INCREASED 3 0.0004
700 DYSLIPIDAEMIA 2 0.0004
701 LIPASE INCREASED 3 0.0004
702 RENAL FAILURE CHRONIC 3 0.0004
703 CEREBRAL ISCHAEMIA 2 0.0004
704 INFECTION 56 0.0004
705 LEUKOCYTOSIS 7 0.0004
706 OSTEOMYELITIS 7 0.0004
707 APNOEA 3 0.0004
708 AFFECTIVE DISORDER 3 0.0004
709 MOUTH ULCERATION 8 0.0004
710 PULMONARY OEDEMA 17 0.0004
711 ATRIAL FLUTTER 3 0.0004
712 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
713 LACTIC ACIDOSIS 12 0.0004
714 CHEILITIS 2 0.0004
715 COLITIS 14 0.0004
716 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
717 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0004
718 ACUTE CORONARY SYNDROME 3 0.0004
719 PERICARDITIS 6 0.0004
720 ANGIOPATHY 2 0.0004
721 SKIN INFECTION 4 0.0004
722 BLOOD CALCIUM DECREASED 4 0.0004
723 SINUS TACHYCARDIA 5 0.0004
724 RED BLOOD CELL COUNT DECREASED 10 0.0003
725 BLOOD MAGNESIUM DECREASED 3 0.0003
726 HAEMATOMA 9 0.0003
727 BLOOD URIC ACID INCREASED 2 0.0003
728 ELECTROLYTE IMBALANCE 4 0.0003
729 METABOLIC ACIDOSIS 11 0.0003
730 IMMUNOSUPPRESSION 3 0.0003
731 BLISTER 19 0.0003
732 RESPIRATORY RATE INCREASED 3 0.0003
733 PULMONARY HYPERTENSION 7 0.0003
734 RASH ERYTHEMATOUS 16 0.0003
735 PALLOR 9 0.0003
736 LETHARGY 19 0.0003
737 DISORIENTATION 13 0.0003
738 CYTOPENIA 4 0.0003
739 LIVER FUNCTION TEST INCREASED 7 0.0003
740 OVARIAN CANCER 3 0.0003
741 AMNESIA 21 0.0003
742 EXTRAPYRAMIDAL DISORDER 8 0.0003
743 HEPATIC STEATOSIS 6 0.0003
744 NEPHROPATHY 3 0.0003
745 BLOOD SODIUM DECREASED 6 0.0003
746 HAEMATEMESIS 8 0.0003
747 POST PROCEDURAL COMPLICATION 6 0.0003
748 RASH PAPULAR 7 0.0003
749 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
750 RHABDOMYOLYSIS 13 0.0003
751 INFLAMMATION 16 0.0003
752 GASTRITIS 8 0.0003
753 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
754 HYPONATRAEMIA 17 0.0003
755 BRONCHIECTASIS 2 0.0003
756 OEDEMA PERIPHERAL 36 0.0003
757 SUBARACHNOID HAEMORRHAGE 3 0.0003
758 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
759 TENDERNESS 3 0.0003
760 OFF LABEL USE 252 0.0003
761 AUTOIMMUNE HEPATITIS 2 0.0003
762 PETECHIAE 3 0.0003
763 DUODENAL ULCER 2 0.0003
764 CHOLELITHIASIS 9 0.0003
765 BLINDNESS TRANSIENT 2 0.0003
766 CONDITION AGGRAVATED 81 0.0003
767 BLOOD POTASSIUM DECREASED 8 0.0003
768 DYSARTHRIA 10 0.0003
769 BLOOD URINE PRESENT 5 0.0003
770 GASTRIC ULCER 5 0.0003
771 DEATH 226 0.0003
772 HAEMORRHAGE 27 0.0003
773 EYELID OEDEMA 3 0.0003
774 POST PROCEDURAL HAEMORRHAGE 3 0.0003
775 LOSS OF CONSCIOUSNESS 33 0.0003
776 VASCULITIS 3 0.0003
777 ORAL HERPES 5 0.0003
778 BLOOD PRESSURE DECREASED 17 0.0003
779 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
780 HALLUCINATION 19 0.0003
781 MENTAL STATUS CHANGES 7 0.0003
782 MEDICATION ERROR 14 0.0003
783 HALLUCINATION, AUDITORY 4 0.0003
784 PRODUCTIVE COUGH 12 0.0003
785 ASPHYXIA 2 0.0002
786 CARDIOMEGALY 3 0.0002
787 PULMONARY EMBOLISM 23 0.0002
788 PHARYNGITIS 3 0.0002
789 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
790 PRODUCT USE ISSUE 45 0.0002
791 HEMIPARESIS 4 0.0002
792 ANAPHYLACTIC REACTION 13 0.0002
793 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
794 ABDOMINAL PAIN 54 0.0002
795 OXYGEN SATURATION DECREASED 13 0.0002
796 BLOOD CALCIUM INCREASED 2 0.0002
797 ADVERSE REACTION 3 0.0002
798 ANAL INCONTINENCE 2 0.0002
799 HYPERGLYCAEMIA 8 0.0002
800 PERIPHERAL COLDNESS 3 0.0002
801 RESPIRATORY ARREST 6 0.0002
802 ADVERSE EVENT 20 0.0002
803 RASH 94 0.0002
804 DEEP VEIN THROMBOSIS 14 0.0002
805 APPENDICITIS 2 0.0002
806 SKIN EXFOLIATION 18 0.0002
807 HEPATIC CIRRHOSIS 4 0.0002
808 DIALYSIS 3 0.0002
809 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
810 OVERDOSE 45 0.0002
811 LOCALISED INFECTION 5 0.0002
812 GASTROENTERITIS 3 0.0002
813 PLASMA CELL MYELOMA 8 0.0002
814 ACUTE MYOCARDIAL INFARCTION 6 0.0002
815 STOMATITIS 12 0.0002
816 URTICARIA 33 0.0002
817 CARDIOVASCULAR DISORDER 5 0.0002
818 BODY TEMPERATURE INCREASED 4 0.0002
819 DRUG ADMINISTRATION ERROR 6 0.0002
820 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
821 SKIN ULCER 5 0.0002
822 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
823 DERMATITIS 4 0.0002
824 DYSURIA 7 0.0002
825 CHILLS 22 0.0002
826 DRUG EFFECT DECREASED 10 0.0002
827 HYPOGLYCAEMIA 9 0.0002
828 DIABETES MELLITUS 14 0.0002
829 ASPIRATION 2 0.0002
830 ERYTHEMA 37 0.0002
831 CHROMATURIA 4 0.0002
832 AGITATION 13 0.0002
833 HERPES ZOSTER 10 0.0002
834 BLINDNESS 7 0.0002
835 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
836 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
837 HEART RATE DECREASED 6 0.0002
838 COVID-19 PNEUMONIA 2 0.0002
839 URINARY INCONTINENCE 5 0.0002
840 ISCHAEMIC STROKE 3 0.0002
841 CHOLECYSTITIS 2 0.0002
842 RASH PRURITIC 9 0.0002
843 INFUSION RELATED REACTION 11 0.0002
844 APHASIA 5 0.0002
845 THERAPEUTIC RESPONSE DECREASED 10 0.0002
846 MENTAL DISORDER 7 0.0002
847 URINARY TRACT INFECTION 27 0.0002
848 ANOREXIA 2 0.0002
849 RASH GENERALISED 4 0.0002
850 HAEMORRHOIDS 3 0.0002
851 BEDRIDDEN 2 0.0002
852 CHEST PAIN 28 0.0002
853 URINARY RETENTION 5 0.0001
854 FULL BLOOD COUNT DECREASED 3 0.0001
855 HYPERTENSION 31 0.0001
856 HAEMATOCHEZIA 8 0.0001
857 POLLAKIURIA 6 0.0001
858 COORDINATION ABNORMAL 2 0.0001
859 LYMPHADENOPATHY 5 0.0001
860 PAIN IN JAW 4 0.0001
861 AGGRESSION 7 0.0001
862 FAECES DISCOLOURED 3 0.0001
863 DRUG EFFECT INCOMPLETE 5 0.0001
864 CARDIAC FAILURE CONGESTIVE 11 0.0001
865 RESTLESSNESS 5 0.0001
866 TOXICITY TO VARIOUS AGENTS 23 0.0001
867 DIARRHOEA 88 0.0001
868 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
869 HYPERSENSITIVITY 25 0.0001
870 EPISTAXIS 10 0.0001
871 CORONARY ARTERY DISEASE 4 0.0001
872 BLOOD CHOLESTEROL INCREASED 6 0.0001
873 EJECTION FRACTION DECREASED 2 0.0001
874 CONSTIPATION 28 0.0001
875 SLEEP DISORDER 9 0.0001
876 CYANOSIS 2 0.0001
877 NEUROPATHY PERIPHERAL 12 0.0001
878 ABDOMINAL DISTENSION 13 0.0001
879 PRESYNCOPE 3 0.0001
880 BLOOD POTASSIUM INCREASED 2 0.0001
881 OSTEOPOROSIS 5 0.0001
882 VIRAL INFECTION 4 0.0001
883 SKIN DISORDER 4 0.0001
884 BLOOD GLUCOSE INCREASED 22 0.0001
885 DIPLOPIA 3 0.0001
886 ECZEMA 6 0.0001
887 RASH MACULAR 4 0.0001
888 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
889 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
890 END STAGE RENAL DISEASE 2 0.0001
891 ACCIDENTAL OVERDOSE 4 0.0001
892 TREMOR 18 0.0001
893 BRONCHITIS 8 0.0001
894 OROPHARYNGEAL PAIN 10 0.0001
895 CONJUNCTIVITIS 2 0.0001
896 INTESTINAL OBSTRUCTION 4 0.0001
897 MYALGIA 18 0.0001
898 SOMNOLENCE 21 0.0001
899 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
900 ABNORMAL BEHAVIOUR 4 0.0001
901 BLOOD PRESSURE ABNORMAL 2 0.0001
902 GASTROINTESTINAL DISORDER 9 0.0001
903 FLUID RETENTION 5 0.0001
904 CHEST DISCOMFORT 10 0.0001
905 LUNG NEOPLASM MALIGNANT 4 0.0001
906 CARDIAC DISORDER 9 0.0001
907 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
908 MUSCULOSKELETAL PAIN 5 0.0001
909 BACK PAIN 22 0.0001
910 OSTEOARTHRITIS 4 0.0001
911 HYPOTHYROIDISM 3 0.0001
912 RECTAL HAEMORRHAGE 4 0.0001
913 OSTEONECROSIS 3 0.0001
914 VISUAL ACUITY REDUCED 3 0.0001
915 DYSPNOEA 51 0.0001
916 DEHYDRATION 12 0.0001
917 COUGH 25 0.0001
918 TYPE 2 DIABETES MELLITUS 3 0.0001
919 PARAESTHESIA 14 0.0001
920 SINUSITIS 9 0.0001
921 INJECTION SITE REACTION 6 0.0001
922 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
923 PRURITUS 33 0.0001
924 VOMITING 40 0.0001
925 DISEASE RECURRENCE 4 0.0001
926 BLOOD PRESSURE FLUCTUATION 2 0.0001
927 BLOOD GLUCOSE DECREASED 4 0.0001
928 NO ADVERSE EVENT 15 0.0001
929 DYSPNOEA EXERTIONAL 3 0.0001
930 SWELLING FACE 5 0.0001
931 NAUSEA 60 0.0001
932 THROMBOSIS 6 0.0001
933 DISTURBANCE IN ATTENTION 4 0.0001
934 ABNORMAL DREAMS 2 0.0001
935 MUSCULAR WEAKNESS 8 0.0001
936 HYPOACUSIS 3 0.0001
937 UNDERDOSE 5 0.0001
938 ANGIOEDEMA 3 0.0001
939 COLITIS ULCERATIVE 3 0.0001
940 IRRITABILITY 4 0.0001
941 INCORRECT DOSE ADMINISTERED 15 0.0001
942 VISION BLURRED 9 0.0001
943 NEPHROLITHIASIS 3 0.0001
944 SKIN DISCOLOURATION 3 0.0001
945 VISUAL IMPAIRMENT 8 0.0001
946 ARTHRITIS 5 0.0001
947 INFLUENZA 7 0.0001
948 DECREASED APPETITE 14 0.0001
949 CEREBROVASCULAR ACCIDENT 10 0.0001
950 FLUSHING 6 0.0001
951 MYOCARDIAL INFARCTION 10 0.0001
952 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
953 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
954 WEIGHT INCREASED 12 0.0001
955 HOT FLUSH 4 0.0001
956 CHRONIC KIDNEY DISEASE 4 0.0001
957 PAIN IN EXTREMITY 15 0.0001
958 ARTHRALGIA 21 0.0001
959 SYNCOPE 5 0.0000
960 ILL-DEFINED DISORDER 3 0.0000
961 VERTIGO 3 0.0000
962 DYSKINESIA 2 0.0000
963 ASTHENIA 18 0.0000
964 HEADACHE 29 0.0000
965 BLOOD PRESSURE INCREASED 7 0.0000
966 MALAISE 20 0.0000
967 HOSPITALISATION 7 0.0000
968 ABDOMINAL PAIN UPPER 9 0.0000
969 SWELLING 4 0.0000
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
971 DYSPHAGIA 4 0.0000
972 MOBILITY DECREASED 3 0.0000
973 INSOMNIA 11 0.0000
974 PAIN 25 0.0000
975 HEART RATE INCREASED 4 0.0000
976 HYPERHIDROSIS 5 0.0000
977 DEPRESSED MOOD 2 0.0000
978 DEPRESSION 8 0.0000
979 CATARACT 2 0.0000
980 FALL 11 0.0000
981 DRUG INTOLERANCE 3 0.0000
982 FATIGUE 24 0.0000
983 ALOPECIA 6 0.0000
984 ABDOMINAL DISCOMFORT 5 0.0000
985 ANXIETY 8 0.0000
986 ACNE 2 0.0000
987 PALPITATIONS 3 0.0000
988 BALANCE DISORDER 2 0.0000
989 DRY SKIN 3 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
991 WEIGHT DECREASED 6 0.0000
992 DYSPEPSIA 2 0.0000
993 PERIPHERAL SWELLING 3 0.0000
994 DIZZINESS 9 0.0000
995 COVID-19 3 0.0000
996 DRUG DOSE OMISSION 2 0.0000